Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-02
2007-01-02
Owens, Amelia A. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C549S424000, C549S425000
Reexamination Certificate
active
10494243
ABSTRACT:
The invention relates to compounds of general formula (I); in which R is an amino or guanidino group; R2is acetyl or trifluoroacetyl; X is CONH, SO2NH, NHCO or NHCONH; m is either 0 or 1; n is an integer from 2 to 6; q is an integer from 0 to 3; and Y is hydrogen or an aromatic substituent, or a pharmaceutically acceptable derivative thereof; methods for their preparation, pharmaceutical formulations containing them or their use in the prevention or treatment of a viral infection
REFERENCES:
patent: 6548476 (2003-04-01), Wu et al.
patent: WO 00/55149 (2000-09-01), None
patent: WO 02/20514 (2002-03-01), None
McDonald, SJF et al ‘Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influena neuraminidase including H5n1 avian’ CA 142:423048 (2005).
Fleming, DM ‘Managing influenza: amantadine, rimantadine and beyond’ PMID: 11351773 (2001).
Dowle Michael D.
Jin Betty
MacDonald Simon J. F.
Mason Andrew McM
McConnell Darryl
Biota Scientific Management Pty. Ltd.
Foley & Lardner LLP
Owens Amelia A.
LandOfFree
Dimeric compounds and their use as anti-viral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dimeric compounds and their use as anti-viral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dimeric compounds and their use as anti-viral agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3813044